Image source: Retha Ferguson.

A COVID-19 vaccine out of Oxford University has passed the first phase of testing with flying colours.

Results from testing in 1,077 healthy adults have indicated it is a safe vaccine. It has shown to successfully produce an immune response however it remains unclear whether it can effectively tackle COVID-19.

To find out more about this vaccine candidate, The Wire’s Aidan Moller spoke with Dr Paul Griffin, a Director of Infectious Disease at Mater Health Services and Associate Professor of Medicine at the University of Queensland.

Download Audio

The Wire is produced in partnership by

Contributor Stations

Supporters and Program Distribution